1 |
Verhoeff K, Dang JT, Deprato A, et al. Surgical management of hiatal hernia vs medical therapy to treat bleeding Cameron lesions: a systematic review and meta-analysis[J]. Surg Endosc, 2020, 35(12): 7154-7162.
|
2 |
陈双,周太成,马宁.食管裂孔疝的病理生理[J/OL].中华胃食管反流病电子杂志, 2019, 6(2): 49-54.
|
3 |
Liu X, Ma Q, Chen J, et al. A protocol for developing core outcome sets for laparoscopic hiatal hernia repair[J]. Trials, 2022, 23(1): 907.
|
4 |
Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects[J]. Circ Res, 2016, 118(9): 1340-1347.
|
5 |
Wu PK, Chen CF, Chung LH, et al. Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis[J]. Thromb Res, 2014, 133(5): 719-724.
|
6 |
Nicholson M, Chan N, Bhagirath V, et al. Prevention of venous thromboembolism in 2020 and beyond[J]. J Clin Med, 2020, 9(8): 2467.
|
7 |
张频.减重手术围手术期静脉血栓栓塞症防治[J].中国实用外科杂志, 2020, 40(4): 387-389.
|
8 |
Duranteau J, Taccone FS, Verhamme P, et al. European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care[J]. Eur J Anaesthesiol, 2018, 35(2): 142-146.
|
9 |
Aminian A, Vosburg RW, Altieri MS, et al. The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery[J]. Surg Obes Relat Dis, 2022, 18(2): 165-174.
|
10 |
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(suppl2): e227S-e277S.
|
11 |
Aminian A, Andalib A, Khorgami Z, et al. Who should get extended thromboprophylaxis after bariatric surgery?: a risk assessment tool to guide indications for post-discharge pharmacoprophylaxis[J]. Ann Surg, 2017, 265(1): 143-150.
|
12 |
Brunetti L, Wassef A, Sadek R, et al. Anticoagulant activity of enoxaparin and unfractionated heparin for venous thromboembolism prophylaxis in obese patients undergoing sleeve gastrectomy[J]. Surg Obes Relat Dis, 2019, 15(3): 363-373.
|
13 |
Schijns W, Deenen MJ, Aarts EO, et al. The effect of obesity on anti-Xa concentrations in bariatric patients[J]. Obes Surg, 2018, 28(7): 1997-2005.
|
14 |
上海市普通外科患者静脉血栓栓塞症防治管理规范(2020版)[J].中国实用外科杂志, 2020, 40(0): 481-487.
|